Breathing technique during EMG to see if pain and anxiety reduce in type 2 diabetes
Official title: The Effect of 4-7-8 Breathing Technique on Pain and Anxiety During Electromyography Procedure in Individuals With Type 2 Diabetes Who Have Diabetic Neuropathy: A Randomized Controlled Study
Run by Hasan Kalyoncu University · NCT07702175 · Data updated 2026-11-12
This study tests whether the 4-7-8 breathing technique can lower pain and anxiety for adults with type 2 diabetes undergoing EMG for diabetic neuropathy.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 70 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Hasan Kalyoncu University Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Osmaniye, Osmaniye) |
| Status | Recruiting |
| Started | July 13, 2026 |
| Main results expected | February 15, 2027 |
| Study ends | April 15, 2027 |
| Registry record updated | November 5, 2026 |
| Trial ID | NCT07702175 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18-70 with type 2 diabetes and diabetic peripheral neuropathy who are referred for EMG and can communicate in Turkish.
✕Probably not a fit
Individuals with severe autonomic neuropathy, respiratory conditions preventing deep breathing, active infections or skin lesions at the EMG site, or other specified exclusions may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized controlled trial investigates whether training and using the 4-7-8 breathing technique during electromyography (EMG) reduces pain and anxiety in adults with type 2 diabetes and diabetic peripheral neuropathy. Participants will be adults aged 18-70 with type 2 diabetes and DN4-confirmed neuropathy undergoing EMG at Osmaniye Training and Research Hospital. The experimental group will practice the breathing technique, while a control group receives standard EMG procedures; outcomes include pain and anxiety measures during EMG. The study addresses a gap in non-pharmacological pain management for EMG-related distress in diabetic patients. Results will help determine if this breathing method can be a simple, non-drug option to improve the EMG experience.
Why it matters
Potential benefit: If successful, patients may experience less pain and anxiety during EMG, potentially improving testing experience and adherence.
How similar studies have gone: There is limited non-pharmacological evidence for pain/anxiety reduction during EMG; this study explores a novel application of the 4-7-8 breathing technique in this context.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Individuals aged 18-70 years who: * Have been diagnosed with Type 2 DM for at least one year, * Have diabetic peripheral neuropathy and are taking medications with a DN4 score \>3, * Are cooperative and can communicate in Turkish. • Do not have orthopedic or surgical contraindications that would prevent them from undergoing testing. Exclusion Criteria: * • Individuals with severe autonomic neuropathy findings (resting tachycardia, etc.), * Individuals with respiratory system diseases that prevent deep breathing, such as COPD and asthma, * Individuals with active infection or compromised skin integrity (dryness, cracks, open wounds, lesions, etc.) in the area where EMG will be performed, * Individuals with a mass (tumor, cystic formation, etc.) in the anatomical area where EMG will be performed, * Individuals with varicose veins (signs of venous insufficiency) in the anatomical area where EMG will be performed, * Individuals with edema in the area where EMG will be performed that may affect the quality of electrophysiological recordings, * Individuals with a dialysis catheter, central venous catheter, or implanted venous port, * Individuals who have used analgesics (painkillers) within 24 hours prior to the procedure, * Individuals who cannot follow breath commands due to hearing or visual impairment. • Individuals with any muscle disease, * Individuals receiving chemotherapy/radiotherapy treatment at any time, * Individuals who have undergone knee, hip, or lumbar surgery, * Pregnant women, * Individuals with any inflammatory rheumatic disease, * Patients with pacemakers or ICDs, * Individuals with chronic kidney failure
Where it's running
-
Osmaniye Training and Research Hospital
Osmaniye, Osmaniye, Turkey (Türkiye) Recruiting
Study contacts
- Study coordinator: Nurgül GÜN, MSc, RN
- Email: nurgul.gun@hku.edu.tr
- Phone: +90 553 869 46 78
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Single-session intervention to change ambiguity aversion
This trial tests whether one brief intervention can change how adults with intolerance of uncertainty and anxiety make ambiguous decisions and how their brains respond.
-
Evaluating human placental membrane products for treating nonhealing diabetic foot and venous leg ulcers
This study is testing whether using human placental products along with regular care can help people with stubborn diabetic foot and leg ulcers heal better.
-
Characterizing diabetes and obesity in Greenlandic patients
This study is trying to learn more about how genetics and environment affect type 2 diabetes and obesity in Greenlandic people, while also looking at related health issues like sleep apnea.
-
Proliverenol for liver fat and insulin resistance in type 2 diabetes
This study tests whether adding Proliverenol to standard diabetes care can improve liver fat and blood sugar control in adults with type 2 diabetes.
-
Whole-Body Vibration Training in Women With Obesity With and Without Type 2 Diabetes
This study tests whether eight weeks of supervised whole-body vibration training changes ankle muscle activity and walking performance in women with obesity, comparing those with and without type 2 diabetes.
-
Acupuncture plus vitamin B12 for diabetic heart nerve damage
This study tests whether adding acupuncture to standard care and vitamin B12 can help adults with type 2 diabetes who have damaged the nerves that control the heart.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.